News
Press Releases

Tuesday, August 14, 2012

Stemedica International Receives Licenses from Swissmedic for Import and Export of its Stemedyne™ Stem Cell Line

Stemedica International, SA (Epalinges, Switzerland), a wholly owned subsidiary of Stemedica Cell Technologies, Inc. (“Stemedica”), a leader in adult stem cell research and manufacturing, announced today that it has been granted a series of licenses by Swissmedic (the Swiss equivalent of the United States Food and Drug Administration). These licenses specifically authorize the Company to… sample of admissions resume http://skatehousemedia.com/cv/write-my-essay/12/ is it illegal to buy a term paper write an essay introduction 14th august essay in urdu https://pacificainexile.org/students/expository-writing-essay/10/ https://www.puente.org/exams/how-to-right-click-on-macbook-air-laptop/13/ best custom essay writers here is it legal to buy viagra from canada online see url andrew jackson term paper source thesis statement for divorce essay writing with style zoloft require prescription in canada https://ds-drupal.haverford.edu/dcc/analytics/?mg=metformin-before-or-after-meals go how to solve algebra 2 problems follow link see url http://los.org/buy/cytotec-venta-en-usa/7/ 700 word essay go site general employment resume samples buy essay login follow url https://comedyhype.com/your-argument/ here http://writeinbk.com/students/essay-paper-websites/24/ Read Entire Article

Thursday, May 24, 2012

Stemedica International and Academic Partner Awarded Swiss Alzeheimer’s and Stem Cell Research Grant.

Stemedica International, Epalinges, Switzerland, a wholly owned subsidiary of Stemedica Cell Technologies, Inc. (San Diego, CA) announced today that it was awarded a grant by the Swiss Commission for Technology and Innovation along with its academic partner, The École Polytechnique Fédérale de Lausanne (EPFL). The 584,522 CHF (approx. 620,000 USD) grant is focused on the…
Read Entire Article
« Newer Entries